Severe anaphylactic reaction to glatiramer acetate with specific IgE.
Rauschka
H
H
Department of Neurology, Hospital Lainz, Vienna, Austria. helmut.rauschka@univie.ac.at
Farina
C
C
Sator
P
P
Gudek
S
S
Breier
F
F
Schmidbauer
M
M
D000328:Adult; D000707:Anaphylaxis / Q000139:chemically induced* / Q000276:immunology* / Q000503:physiopathology; D005260:Female; D000068717:Glatiramer Acetate; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood* / Q000276:immunology; D007074:Immunoglobulin G / Q000097:blood / Q000276:immunology; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000276:immunology; D009103:Multiple Sclerosis / Q000188:drug therapy*; D010455:Peptides / Q000009:adverse effects* / Q000276:immunology; D012882:Skin Tests; D018418:Th2 Cells / Q000187:drug effects / Q000276:immunology
D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D010455:Peptides; D007073:Immunoglobulin E; D000068717:Glatiramer Acetate